News Detail
New Delhi, 6 May 2024: Even as the central government has initiated several efforts to reduce dependence on imports of active pharmaceutical ingredients (APIs) and drug intermediates from the neighbouring country, imports of bulk drugs and intermediates from China out of the over......
View Details
Source : Pharmabiz
active pharmaceutical ingredients
APIs
drug intermediates
bulk drugs
intermediates
DGCI&S
DoP
Covid-19
APIs
production linked incentive
PLI scheme
key starting materials
active pharmaceutical ingredients
Promotion of Bulk Drug Parks
Related News
- Centre plans to establish national regulatory framework for AYUSH: Union Minister Jadhav (18-01-2025)
- Smuggler arrested with 1000 Phensedyl cough syrup bottles, handed over to police (18-01-2025)
- STF of Bengal Police seized consignment of banned Phensedyl cough syrup worth Rs 1.5 crore (18-01-2025)
- DGFT issues new SOP for voluntary disclosure of SCOMET violations (18-01-2025)
- Private bodies providing essential services must fall under RTI Act: CIC (18-01-2025)
- 'In-Depth' Probe in Anaesthesia Drugs Complication Cases in Kashmir (18-01-2025)
- Guidelines to tackle Antimicrobial Resistance with Better Testing Machines (18-01-2025)
- IBM and L’Oreal to use gen AI model for sustainable cosmetic formulation (17-01-2025)
- Medical devices sector shows promising growth (17-01-2025)
- Nichlaul: Police arrested for running shop without license for 12 years (17-01-2025)